A Phase I Biodistribution and Pharmacokinetic Trial of Humanized Monoclonal Antibody Hu3s193 in Patients with Advanced Epithelial Cancers that Express the Lewis-Y Antigen - Concepedia

Concepedia

Publication | Open Access

A Phase I Biodistribution and Pharmacokinetic Trial of Humanized Monoclonal Antibody Hu3s193 in Patients with Advanced Epithelial Cancers that Express the Lewis-Y Antigen

DOI Full Paper Access

73

Citations

34

References

2007

Year

Andrew M. Scott, Niall C. Tebbutt, Fook-Thean Lee, T. Cavicchiolo, Zhanqi Liu, Sanjeev Gill, Aurora Poon, Wendie Hopkins, Fiona E. Smyth, Carmel Murone,

Clinical Cancer Research

Abstract

Hu3S193 is well tolerated and selectively targets tumors, and the long half-life and biological function in vivo of this antibody makes it an attractive potential therapy for patients with Le(y)-expressing cancers.

References

	Year	Citations

Page 1